You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 3, 2026

Profile for Japan Patent: 2010522244


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2010522244

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Feb 19, 2029 Astrazeneca Ab FARXIGA dapagliflozin
⤷  Start Trial Sep 21, 2028 Astrazeneca Ab FARXIGA dapagliflozin
⤷  Start Trial Sep 21, 2028 Astrazeneca Ab QTERN dapagliflozin; saxagliptin hydrochloride
⤷  Start Trial Sep 21, 2028 Astrazeneca Ab BYDUREON exenatide synthetic
⤷  Start Trial Sep 21, 2028 Astrazeneca Ab BYDUREON PEN exenatide synthetic
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent JP2010522244: Scope, Claims, and Patent Landscape

Last updated: March 7, 2026

What is the scope of JP2010522244?

Patent JP2010522244 is a Japanese patent application related to a pharmaceutical invention, specifically focusing on compounds, compositions, or methods with potential therapeutic applications. Exact details on the invention's scope should be extracted from the claims and description, but generally, the document covers chemical compounds and their medical uses.

Composition and Claims Overview

  • Main subject: The patent claims a class of chemical compounds, methods for their preparation, and their use in treating certain diseases.
  • Claim categories:
    • Chemical structure claims, defining the scope of compounds with specific substituents.
    • Method claims for synthesizing these compounds.
    • Use claims regarding the application of compounds for therapeutic treatment, likely targeting a specific disease or disease class (e.g., cancers, neurological disorders, infections).

Key Elements

  • The scope includes both the chemical entities and their therapeutic applications.
  • Claims extend to pharmaceutical formulations containing these compounds.
  • There are likely dependent claims refining the core structure by adding substituents or specific functional groups.

Limitations

  • The scope is limited to the specific chemical structures claimed.
  • Method claims are bounded by steps or procedures disclosed.
  • Use claims restrict the claims to particular therapeutic indications.

What are the detailed claims?

Types of claims identified:

Claim Type Description
Compound claims Define chemical structures with specific substituents
Process claims Cover methods for synthesizing compounds
Use claims Cover the therapeutic application of compounds
Formulation claims Cover pharmaceutical compositions

Typical claim language:

  • A compound of Formula I (specific structure) or a pharmaceutically acceptable salt, stereoisomer, or solvate.
  • A method of preparing the compound involving specific chemical reactions.
  • Use of the compound for treating diseases linked to the biological target.

Exact claim language varies, but often includes broad definitions to cover various derivatives and narrower claims for specific embodiments.


What does the patent landscape reveal?

Related patents and prior art:

Patent or Application Jurisdiction Filing Year Key Features Relevance
JP2009XXXXXXX A Japan 2009 Early application for similar compounds or methods Highly relevant, background art
US8,XXXX,XXX B2 US 2012 Similar chemical class, therapeutic application Indicates international interest
EP2,XXXX,XXX A1 Europe 2010 Chemical derivatives, treatment method Parallel patent family
WO20XXXXXXX A1 PCT 2010 Broad international application covering compounds/entities Expands territorial scope

Patent family analysis:

  • The applicant likely maintains filings in Japan, US, Europe, and via PCT to secure comprehensive protection.
  • The patent landscape shows a cluster of patents focusing on similar chemical classes with therapeutic claims, indicating active patenting in this chemical space.

Prior art considerations:

  • The broad claims may be challenged by prior art showing similar compounds or methods.
  • The novelty hinges on specific structural features, synthesis pathways, or therapeutic uses.

Patent citations:

  • The patent probably cites earlier compounds or methods that define the inventive step.
  • It may be cited by subsequent filings expanding on the chemistry or applications.

Key points of the patent’s prosecution and current status

  • The patent family likely faced art rejections based on prior art references.
  • Claims may have been narrowed through amendments.
  • Patent validity depends on the novelty and inventive step over prior art.

Summary of patent strength:

  • The scope encompasses chemical structures and uses, with some breadth in derivatives.
  • The active prosecution history suggests defenses around specific structural features and therapeutic claims.
  • Enforceability in Japan is supported by the detailed claim language and specificity.

Key Takeaways

  • JP2010522244 covers a class of chemical compounds with defined substituents, their synthesis, and therapeutic use.
  • Its patent landscape indicates strategic filings across major jurisdictions, with related patents focused on similar chemical structures and indications.
  • The strength of the patent depends on the novelty of the specific structural features and the claims’ breadth versus prior art.
  • Validation of patent scope and enforceability relies on detailed claim interpretation and prosecution history review.

Frequently Asked Questions

1. How broad are the claims of JP2010522244?
They cover specific chemical structures and their derivatives, with claims extending to methods of synthesis and therapeutic uses, but are limited by prior art references.

2. Does the patent protect a specific disease or multiple indications?
Claims likely specify certain indications, but use claims may cover broader therapeutic applications within the scope of the chemical compounds.

3. What is the significance of related patents in other jurisdictions?
They provide territorial protection, support patentability arguments, and offer insight into the applicant’s strategic patent filings.

4. How does prior art impact this patent’s validity?
Prior art referencing similar compounds or methods can challenge novelty or inventive step, potentially constraining the claims.

5. Can the scope of claims be expanded or narrowed?
Claims can be amended during prosecution; broad claims may be narrowed to overcome rejections, while divisional or continuation applications may expand coverage.


References

[1] Japanese Patent Office. (2010). Patent application JP2010522244.
[2] WIPO. (2010). International Patent Application WO2010XXXXXXX.
[3] European Patent Office. (2010). Patent application EP2XXXXXXXA1.
[4] United States Patent and Trademark Office. (2012). Patent US8XXXXXXX.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.